Arsenal Capital Partners Acquires Endpoint Clinical and Fortrea Patient Access from Fortrea
March 11, 2024
Arsenal Capital Partners has acquired Fortrea's Endpoint Clinical and Fortrea Patient Access businesses in a divestiture completed June 4, 2024. The sale allows Fortrea to sharpen its focus as a pure‑play CRO while Arsenal will position Endpoint and the Patient Access business for accelerated investment and growth under management led by Sam Osman.
- Buyers
- Arsenal Capital Partners
- Targets
- Endpoint Clinical, Fortrea Patient Access
- Sellers
- Fortrea
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.